Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. AVTR
stocks logo

AVTR

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
AI Stock Picker
AI Stock Picker

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
1.64B
-2.99%
0.216
-20.04%
1.58B
-0.22%
0.206
-10.35%
1.66B
-1.46%
0.231
-3.56%
Estimates Revision
The market is revising Downward the revenue expectations for Avantor, Inc. (AVTR) for FY2025, with the revenue forecasts being adjusted by -1.4% over the past three months. During the same period, the stock price has changed by -16.23%.
Revenue Estimates for FY2025
Revise Downward
down Image
-1.4%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
down Image
-4.8%
In Past 3 Month
Stock Price
Go Down
down Image
-16.23%
In Past 3 Month
Wall Street analysts forecast AVTR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AVTR is 13.86 USD with a low forecast of 12.00 USD and a high forecast of 17.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
10 Analyst Rating
Wall Street analysts forecast AVTR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AVTR is 13.86 USD with a low forecast of 12.00 USD and a high forecast of 17.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Buy
6 Hold
0 Sell
Moderate Buy
Current: 11.150
sliders
Low
12.00
Averages
13.86
High
17.00
Current: 11.150
sliders
Low
12.00
Averages
13.86
High
17.00
Raymond James
Outperform -> Market Perform
downgrade
2025-11-04
Reason
Raymond James
Price Target
2025-11-04
downgrade
Outperform -> Market Perform
Reason
Raymond James downgraded Avantor to Market Perform from Outperform without a price target. The company reported another "frustrating quarter" with a miss on sales, the analyst tells investors in a research note. The firm cites Avantor's reduced guidance and execution risks for the downgrade. Raymond James sees a lack of visibility to continue recommending the shares.
Barclays
Luke Sergott
Overweight -> Equal Weight
downgrade
$15 -> $12
2025-10-30
Reason
Barclays
Luke Sergott
Price Target
$15 -> $12
2025-10-30
downgrade
Overweight -> Equal Weight
Reason
As previously reported, Barclays analyst Luke Sergott downgraded Avantor to Equal Weight from Overweight with a price target of $12, down from $15. The company is not committing to earnings and sales growth next year given the early stages of its strategic review process, the analyst tells investors in a research note. Barclays awaits further details on Avantor's "revival" plan before again recommending the shares.
JPMorgan
Overweight -> Neutral
downgrade
$14 -> $12
2025-10-30
Reason
JPMorgan
Price Target
$14 -> $12
2025-10-30
downgrade
Overweight -> Neutral
Reason
JPMorgan downgraded Avantor to Neutral from Overweight with a price target of $12, down from $14. The company reported another "weak" quarter and its guide-down indicates limited turnaround visibility, the analyst tells investors in a research note. The firm finds it unclear when some of Avantor's "transitory and seemingly idiosyncratic" issues will subside, such as the operational headwinds impacting process chemicals.
Barclays
Luke Sergott
Overweight -> Equal Weight
downgrade
$15 -> $12
2025-10-30
Reason
Barclays
Luke Sergott
Price Target
$15 -> $12
2025-10-30
downgrade
Overweight -> Equal Weight
Reason
Barclays analyst Luke Sergott downgraded Avantor to Equal Weight from Overweight with a price target of $12, down from $15.
Baird
NULL
to
Outperform
upgrade
$15 -> $17
2025-10-24
Reason
Baird
Price Target
$15 -> $17
2025-10-24
upgrade
NULL
to
Outperform
Reason
Baird raised the firm's price target on Avantor to $17 from $15 and keeps an Outperform rating on the shares. The firm updated its model ahead of Q3 results.
Raymond James
Outperform
maintain
$14 -> $16
2025-10-16
Reason
Raymond James
Price Target
$14 -> $16
2025-10-16
maintain
Outperform
Reason
Raymond James raised the firm's price target on Avantor to $16 from $14 and keeps an Outperform rating on the shares. Heading into Q3 earnings, the firm adjusts its 2026-2027 outlook, reflecting expectations for a slower recovery or stabilization in end markets, the analyst tells investors in a research note. These revisions align more closely with recent company commentary and appear broadly in line with current buyside expectations ahead of an earnings season likely to provide greater insight into 2026 trends, the firm says.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Avantor Inc (AVTR.N) is 12.79, compared to its 5-year average forward P/E of 20.49. For a more detailed relative valuation and DCF analysis to assess Avantor Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Undervalued
5Y Average PE
20.49
Current PE
12.79
Overvalued PE
25.02
Undervalued PE
15.97

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
15.56
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
18.13
Undervalued EV/EBITDA
12.99

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
2.21
Current PS
0.00
Overvalued PS
2.70
Undervalued PS
1.71
Intellectia AI SwingMax
Intellectia AI SwingMax

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Financial AI Agent
Financial AI Agent

AVTR News & Events

Events Timeline

(ET)
2025-11-10
08:31:54
Avantor names Mary Blenn as Chief Operating Officer
select
2025-10-29 (ET)
2025-10-29
06:14:00
Avantor unveils $500M share buyback initiative
select
2025-10-29
06:12:56
Avantor announces Q3 adjusted EPS of 22 cents, falling short of the 23 cents consensus.
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
5.0
05:41 AMPRnewswire
Avantor Appoints Sanjeev Mehra to Board of Directors
  • New Board Member: Avantor has appointed Sanjeev Mehra to its Board of Directors, bringing over 30 years of financial industry experience, including serving as Vice Chairman at Goldman Sachs, which is expected to provide valuable strategic guidance to the company.
  • Support for Growth Strategy: Mehra will be involved in implementing the Avantor Revival plan, focusing on accelerating growth and increasing profitability, indicating the company's commitment to future development and strategic direction.
  • Rich Investment Background: As the founding partner of Periphas Capital, Mehra possesses deep expertise in investing in technology-enabled businesses, which will aid Avantor in innovation and market expansion in the tech sector.
  • Diverse Board Experience: Having served on the boards of over 25 companies, Mehra's extensive governance experience will enhance Avantor's decision-making capabilities and market adaptability.
[object Object]
Preview
7.0
01:21 AMGlobenewswire
Avantor and Others Face Class Action Lawsuits; Investors Must Note Deadlines
  • Class Action Alert: Avantor, Inc. (NYSE:AVTR) faces a class action lawsuit for failing to disclose weakened competitive positioning during the period from March 5, 2024, to October 28, 2025, with a lead plaintiff deadline of December 29, 2025, potentially impacting stock price and investor confidence.
  • Competitive Pressure Revealed: Synopsys, Inc. (NASDAQ:SNPS) is accused of not disclosing that its increased focus on AI customers negatively affected its Design IP business from December 4, 2024, to September 9, 2025, with a lead plaintiff deadline of December 30, 2025, reflecting significant market challenges.
  • Growth Prospects Questioned: CarMax, Inc. (NYSE:KMX) is alleged to have overstated growth prospects during the period from June 20, 2025, to November 5, 2025, with a lead plaintiff deadline of January 2, 2026, which may lead to diminished market confidence in future performance.
  • Demand Shortfall Issues: Inspire Medical Systems, Inc. (NYSE:INSP) faces allegations of failing to disclose poor demand for its new treatment from August 6, 2024, to August 4, 2025, with a lead plaintiff deadline of January 5, 2026, indicating significant challenges in product rollout.
[object Object]
Preview
7.0
12-04PRnewswire
Avantor, Inc. Faces Allegations of Misleading Statements; Shareholders Encouraged to Claim
  • Shareholder Claim Notice: The Gross Law Firm has issued a notice encouraging shareholders who purchased Avantor (NYSE:AVTR) shares between March 5, 2024, and October 28, 2025, to contact them for potential lead plaintiff appointment, indicating significant legal risks for the company.
  • Allegations of Misleading Statements: The lawsuit alleges that Avantor made materially false and misleading statements during this period, failing to disclose its weaker competitive positioning and the negative impacts from increased competition, which could lead to shareholder losses.
  • Claim Deadline: Shareholders must register by December 29, 2025, to participate in the class action, highlighting the urgency of the company's legal liabilities and potential impacts on its stock performance.
  • Next Steps for Legal Proceedings: Once registered, shareholders will receive status updates throughout the lifecycle of the case, demonstrating transparency in legal matters and a commitment to protecting shareholder rights.
Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Avantor Inc (AVTR) stock price today?

The current price of AVTR is 11.15 USD — it has decreased -1.24 % in the last trading day.

arrow icon

What is Avantor Inc (AVTR)'s business?

Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.

arrow icon

What is the price predicton of AVTR Stock?

Wall Street analysts forecast AVTR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AVTR is 13.86 USD with a low forecast of 12.00 USD and a high forecast of 17.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Avantor Inc (AVTR)'s revenue for the last quarter?

Avantor Inc revenue for the last quarter amounts to 1.62B USD, decreased -5.28 % YoY.

arrow icon

What is Avantor Inc (AVTR)'s earnings per share (EPS) for the last quarter?

Avantor Inc. EPS for the last quarter amounts to -1.04 USD, decreased -1400.00 % YoY.

arrow icon

What changes have occurred in the market's expectations for Avantor Inc (AVTR)'s fundamentals?

The market is revising Downward the revenue expectations for Avantor, Inc. (AVTR) for FY2025, with the revenue forecasts being adjusted by -1.4% over the past three months. During the same period, the stock price has changed by -16.23%.
arrow icon

How many employees does Avantor Inc (AVTR). have?

Avantor Inc (AVTR) has 13500 emplpoyees as of December 05 2025.

arrow icon

What is Avantor Inc (AVTR) market cap?

Today AVTR has the market capitalization of 7.60B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free